(Circulation. 1999;99:2283-2289.)
© 1999 American Heart Association, Inc.
Clinical Investigation and Reports |
From the National Heart Institute, Inaba, Cairo, Egypt (A.E.-S.); Montreal General Hospital, Montreal, Quebec, Canada (T.H.); and the Clinical Cardiac Electrophysiology Laboratories of the Harvard Thorndike Electrophysiology Institute and Arrhythmia Services at Beth Israel Deaconess Medical Center, Boston, Mass (P.P., K.M., L.E., M.E.J.).
Correspondence to Mark E. Josephson, MD, Director of the Harvard Thorndike Electrophysiology Institute, Beth Israel Deaconess Medical Center, 330 Brookline Ave RW453, Boston, MA 02215. E-mail mjoseph2{at}bidmc.harvard.edu
Background-A variety of mapping criteria have been proposed to localize critical sites at which radiofrequency (RF) can predictably terminate reentrant ventricular tachycardia (VT) caused by coronary artery disease. The purpose of this study was to determine the accuracy of using a combination of 3 mapping criteria in predicting termination of VT by a single RF lesion.
Methods and Results-Fifteen consecutive patients with
coronary artery disease and recurrent sustained VT underwent an
attempted RF ablation of 20 monomorphic VTs. Successful termination of
VT by a single RF lesion was predicted if all the following mapping
criteria were met: (1) an exact QRS match in the 12-lead ECG during
entrainment; (2) a return cycle length
10 ms of the VT cycle length;
(3) presystolic potentials (<70% of VT cycle length) with an
activation time to the QRS within 10 ms of the stimulus to QRS.
Inability to meet these 3 criteria was considered to predict failure of
VT termination by RF energy at that site. RF ablation was applied to 44
left ventricular sites in 20 VTs at which at least 1 of the
mapping criteria was met. VT was terminated with a single RF lesion in
19 of 19 sites meeting all criteria; RF failed to terminate VT at 24 of
25 sites at which all 3 criteria were not met
(P<0.0005).
Conclusions-To maximize success and minimize the number of RF lesions in patients with infarct-related VT, all the above 3 mapping criteria should be met before the application of RF energy.
Key Words: catheter ablation tachycardia mapping coronary artery disease
This article has been cited by other articles:
![]() |
J. J. Blanc, J. Almendral, M. Brignole, M. Fatemi, K. Gjesdal, E. Gonzalez-Torrecilla, P. Kulakowski, G. Y.H. Lip, D. Shah, C. Wolpert, et al. Consensus document on antithrombotic therapy in the setting of electrophysiological procedures Europace, May 1, 2008; 10(5): 513 - 527. [Full Text] [PDF] |
||||
![]() |
H. Doppalapudi, T. Yamada, H. T. McElderry, V. J. Plumb, A. E. Epstein, and G. N. Kay Ventricular Tachycardia Originating From the Posterior Papillary Muscle in the Left Ventricle: A Distinct Clinical Syndrome Circ Arrhythmia Electrophysiol, April 1, 2008; 1(1): 23 - 29. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Almendral and M. E. Josephson All Patients With Hemodynamically Tolerated Postinfarction Ventricular Tachycardia Do Not Require an Implantable Cardioverter-Defibrillator Circulation, September 4, 2007; 116(10): 1204 - 1212. [Full Text] [PDF] |
||||
![]() |
W. G. Stevenson and K. Soejima Catheter Ablation for Ventricular Tachycardia Circulation, May 29, 2007; 115(21): 2750 - 2760. [Full Text] [PDF] |
||||
![]() |
H. U. Klemm, R. Ventura, D. Steven, C. Johnsen, T. Rostock, B. Lutomsky, T. Risius, T. Meinertz, and S. Willems Catheter Ablation of Multiple Ventricular Tachycardias After Myocardial Infarction Guided by Combined Contact and Noncontact Mapping Circulation, May 29, 2007; 115(21): 2697 - 2704. [Abstract] [Full Text] [PDF] |
||||
![]() |
Developed in Collaboration With the European Heart, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al. ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) J. Am. Coll. Cardiol., September 5, 2006; 48(5): e247 - e346. [Full Text] [PDF] |
||||
![]() |
Writing Committee Members, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society Europace, September 1, 2006; 8(9): 746 - 837. [Full Text] [PDF] |
||||
![]() |
V. Y. Reddy, P. Neuzil, M. Taborsky, and J. N. Ruskin Short-term results of substrate mapping and radiofrequency ablation of ischemic ventricular tachycardia using a saline-irrigated catheter J. Am. Coll. Cardiol., June 18, 2003; 41(12): 2228 - 2236. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Strohmer and C. Hwang Ablation of postinfarction ventricular tachycardia guided by isolated diastolic potentials Europace, January 1, 2003; 5(4): 375 - 380. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Zuliani, A. Cherubini, S. Volpato, E. Palmieri, P. Mecocci, P. De Rango, P. Cao, F. Costantini, A. Mezzetti, F. Mascoli, et al. Genetic Factors Associated With the Absence of Atherosclerosis in Octogenarians J. Gerontol. A Biol. Sci. Med. Sci., September 1, 2002; 57(9): M611 - 615. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. Morton, P. Sanders, V. Deen, J. K. Vohra, and J. M. Kalman Sensitivity and specificity of concealed entrainment for the identification of a critical isthmus in the atrium: relationship to rate, anatomic location and antidromic penetration J. Am. Coll. Cardiol., March 6, 2002; 39(5): 896 - 906. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Josephson, D. J. Callans, and A. E. Buxton The Role of the Implantable Cardioverter-Defibrillator for Prevention of Sudden Cardiac Death Ann Intern Med, December 5, 2000; 133(11): 901 - 910. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |